You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

iPSC

Showing 1 - 25 of 80
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

iPSC Repository of Pediatric Cardiovascular Disease

Recruiting
  • Congenital Heart Disease
  • Heart Diseases
  • Blood draw
  • Columbus, Ohio
    Nationwide Children's Hospital
Sep 20, 2022

ImplementingNational Biobank of PD With WGS and Functional

Not yet recruiting
  • Parkinson Disease
  • REM Sleep Behavior Disorder
  • whole genome sequencing
  • Pozzilli, Italy
    IRCCS Neuromed
Feb 13, 2023

Severe Asthma, Allergic Bronchopulmonary Aspergillosis (ABPA) Trial in Montpellier (Blood sample)

Recruiting
  • Severe Asthma
  • Allergic Bronchopulmonary Aspergillosis (ABPA)
  • Blood sample
  • Montpellier, France
    university Hospital of Montpellier
Dec 2, 2022

Macular Degeneration Trial in Beijing (Autologous iPSC-derived RPE)

Recruiting
  • Macular Degeneration
  • Autologous iPSC-derived RPE
  • Beijing, Beijing, China
    Beijing Tongren Hospitol,Capital Medical University
Jun 30, 2022

Human iPSC for Repair of Vasodegenerative Vessels in Diabetic

Recruiting
  • Diabetes Complications
  • Diabetic Retinopathy
  • Generation of inducible pluripotent stem cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
May 17, 2022

AML, Adult Trial in Hangzhou (CLL1 CAR-NK cell injection)

Recruiting
  • AML, Adult
  • CLL1 CAR-NK cell injection
  • Hangzhou, Zhejiang, China
    Clinical research ethics committee of the first affiliated hospi
Aug 30, 2023

Ischemic Heart Failure, Chronic Heart Failure Trial in Changsha, Nanjing (Human (allogeneic) iPS-cell-derived cardiomyocyte)

Not yet recruiting
  • Ischemic Heart Failure
  • Chronic Heart Failure
  • Human (allogeneic) iPS-cell-derived cardiomyocyte
  • Changsha, Hunan, China
  • +1 more
Oct 12, 2022

Refractory Focal Epilepsy Trial in Beijing (iPSC-Exos)

Recruiting
  • Refractory Focal Epilepsy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 5, 2023

Acute Ischemic Stroke Trial in Beijing (iEPCs, Clinical standard treatment (CST))

Not yet recruiting
  • Acute Ischemic Stroke
  • iEPCs
  • Clinical standard treatment (CST)
  • Beijing, Beijing, China
    Allife
Aug 14, 2023

Production of iPSC Derived RPE Cells for Transplantation in AMD

Completed
  • Age Related Macular Degeneration (AMD)
    • (no location specified)
    Apr 4, 2022

    Univentricular Heart, Congenital Heart Disease, Heart Failure NYHA Class III Trial (iPSC-CL)

    Not yet recruiting
    • Univentricular Heart
    • +3 more
    • iPSC-CL
    • (no location specified)
    Dec 9, 2022

    Generation of Cancer Antigen-Specific T-cells From Human Induced

    Terminated
    • Gastrointestinal Cancers
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Nov 9, 2021

      iPSC Neurons From Adult Survivors of Childhood Cancer Who Have

      Active, not recruiting
      • Leukemia
      • Lymphoma
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        May 16, 2022

        Cardiovascular Diseases, CHF, Dilated Cardiomyopathy Trial in Nanjing (hiPSC-CM therapy)

        Recruiting
        • Cardiovascular Diseases
        • +2 more
        • hiPSC-CM therapy
        • Nanjing, Jiangsu, China
          Help Therapeutics
        Mar 24, 2022

        Age-Related Macular Degeneration Trial run by the NEI (iPSC-derived RPE/PGLA transplantation)

        Recruiting
        • Age-Related Macular Degeneration
        • iPSC-derived RPE/PLGA transplantation
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 28, 2023

        Induced Pluripotent Stem Cells for Development of Novel Drug

        Recruiting
        • Inborn Errors of Metabolism
        • Skin biopsy
        • Withdraw of blood
        • Lahore, Pakistan
          Children Hospital and Institute of Child Health
        May 14, 2021

        Amyotrophic Lateral Sclerosis Trial in Japan (Bosutinib)

        Recruiting
        • Amyotrophic Lateral Sclerosis
        • Kyoto, Japan
        • +3 more
        Feb 3, 2021

        Assessing Causality of CREBBP and EP300 Variants.

        Recruiting
        • Rubinstein-Taybi Syndrome
        • skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 SRT patients included.
        • +4 more
        • Talence, France
          Centre Hospitalier Universitaire de Bordeaux
        Oct 7, 2021

        Brain Tumor, Kidney Tumor, Neuroblastoma Trial in Villejuif (Skin biopsy, Fresh tumor sample, Blood sample)

        Recruiting
        • Brain Tumor
        • +3 more
        • Skin biopsy
        • +4 more
        • Villejuif, France
          Gustave Roussy
        May 26, 2023

        AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

        Not yet recruiting
        • AML, Adult
        • Minimal Residual Disease
        • CD33/CLL1 dual CAR-NK cell
        • +5 more
        • Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Aug 4, 2023

        Parkinson's Disease Trial in Shanghai (hiPSC-DAP)

        Not yet recruiting
        • Parkinson's Disease
        • hiPSC-DAP
        • Shanghai, Shanghai, China
          Shanghai East Hospital
        Nov 22, 2023

        Atypical Hemolytic Uremic Syndrome Trial in Ranica (Blood sampling and urine analysis)

        Not yet recruiting
        • Atypical Hemolytic Uremic Syndrome
        • Blood sampling and urine analysis
        • Ranica, BG, Italy
          Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
        Mar 28, 2023

        Stem Cells in NF1 Tumors of the Central Nervous System

        Suspended
        • Neurofibromatosis Type 1
        • Tumors of the Central Nervous System
        • Collection of Stem Cells
        • Washington, District of Columbia
          Children's National Medical Center
        Mar 8, 2022

        Advanced Solid Tumors, Lymphoma, Gastric Cancer Trial in United States (FT500, Nivolumab, Pembrolizumab)

        Completed
        • Advanced Solid Tumors
        • +17 more
        • San Diego, California
        • +3 more
        Jan 27, 2023

        Atopic Dermatitis Trial in Beijing (GD-iExo-001, normal saline)

        Recruiting
        • Atopic Dermatitis
        • Beijing, Beijing, China
          Chinese Academy of Medical Science & Peking Union Medical Colleg
        Jul 23, 2023